NCT02863692Recruiting
Registry of the German CLL Study Group
Registry of the German CLL Study Group Long Term Follow-up of Patients With CLL, B-PLL, T-PLL, SLL,T or NK-LGL, HCL and Richter's Transformation
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
Long term follow-up of patients with chronic lymphocytic leukemia (CLL), B-prolymphocytic leukemia (B-PLL), T-cell prolymphocytic leukemia (T-PLL), Small lymphocytic lymphoma (SLL), T/Natural Killer large granular lymphocyte leukemia (T or NK-LGL), Hairy cell leukemia (HCL) and Richter's transformation
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 26 Feb 2015
- Start date
- Aug 2013
- Primary completion date
- Dec 2026
- Lead sponsor
- German CLL Study Group
- Diseases
- Chronic lymphocytic leukaemia
- NCT number
- NCT02863692
What you commit to
- Study type: Observational
- Planned participants: 8000
- From Aug 2013 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients without confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK- LGL, HCL or Richter's transformation
- Cerebral dysfunction, legal incapacity
Who the study is looking for
- Confirmed diagnosis of CLL, B-PLL, T-PLL, SLL, T or NK-LGL, HCL or Richter's transformation
- 18 years of age or older
- Signed, written informed consent
- Presence of one or more of the following disease situations:
- Newly diagnosed patients without treatment indication (eligible for watch and wait Approach Treatment within a clinical trial according to the AMG or status post participation in a clinical Trial)
- Treatment with standard therapies approved for the eligible entities or status post treatment (outside of clinical trials)
- Referral for evaluation the indication for HSCT
- Relapsed disease status (even if first diagnosis was prior to activation of the registry)
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| BAG Freiberg-Richter, Jacobasch, Wolf, Illmer Coordinator of this site? Confirm its status | Dresden | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.